Pylarify (piflufolastat f 18) injection

Ended Awarded

Contract number
36C25725F0080
Awardee
Awarding agency
Obligated
$721,744

Award facts

Contract value 100% obligated
$721,744.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
North Billerica, Billerica, MA 01862, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer.

The contract, valued at $721,744.00, is a delivery order with a firm fixed-price pricing type. It was awarded on May 1, 2025, with an ultimate completion date of April 30, 2026. The awarding agency is the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 17 (VISN 17).

This contract is not set aside for small businesses. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, is a prominent federal contractor that provides critical medical imaging products and radiopharmaceuticals to various federal healthcare providers, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH) Clinical Center.

Quick answers

Who was awarded contract 36C25725F0080?

36C25725F0080 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on May 1, 2025.

How much is contract 36C25725F0080 worth?

The government has obligated $721,744 on 36C25725F0080.

Is contract 36C25725F0080 an order under another contract?

Yes. 36C25725F0080 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25725F0080 competed?

The extent of competition for 36C25725F0080 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award